CN105440065A - 一种萘酰亚胺-氟硼二吡咯荧光分子np-bodipy及其制备方法和应用 - Google Patents
一种萘酰亚胺-氟硼二吡咯荧光分子np-bodipy及其制备方法和应用 Download PDFInfo
- Publication number
- CN105440065A CN105440065A CN201510766781.XA CN201510766781A CN105440065A CN 105440065 A CN105440065 A CN 105440065A CN 201510766781 A CN201510766781 A CN 201510766781A CN 105440065 A CN105440065 A CN 105440065A
- Authority
- CN
- China
- Prior art keywords
- fluorescence
- bodipy
- naphthalimide
- pyrroles
- fluorine boron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052796 boron Inorganic materials 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- OVTCUIZCVUGJHS-UHFFFAOYSA-N dipyrrin Chemical compound C=1C=CNC=1C=C1C=CC=N1 OVTCUIZCVUGJHS-UHFFFAOYSA-N 0.000 title abstract 2
- 239000002105 nanoparticle Substances 0.000 claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 13
- 238000002866 fluorescence resonance energy transfer Methods 0.000 claims abstract description 10
- 210000004881 tumor cell Anatomy 0.000 claims abstract description 9
- 238000006736 Huisgen cycloaddition reaction Methods 0.000 claims abstract description 4
- 150000003233 pyrroles Chemical class 0.000 claims description 45
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 35
- 229910052731 fluorine Inorganic materials 0.000 claims description 35
- 239000011737 fluorine Substances 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- LIQLLTGUOSHGKY-UHFFFAOYSA-N [B].[F] Chemical compound [B].[F] LIQLLTGUOSHGKY-UHFFFAOYSA-N 0.000 claims description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 11
- XJHABGPPCLHLLV-UHFFFAOYSA-N benzo[de]isoquinoline-1,3-dione Chemical compound C1=CC(C(=O)NC2=O)=C3C2=CC=CC3=C1 XJHABGPPCLHLLV-UHFFFAOYSA-N 0.000 claims description 9
- 238000003384 imaging method Methods 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 4
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 claims description 3
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 3
- 229960005055 sodium ascorbate Drugs 0.000 claims description 3
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 3
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 30
- 239000000377 silicon dioxide Substances 0.000 abstract description 15
- 239000000975 dye Substances 0.000 abstract description 14
- 239000007850 fluorescent dye Substances 0.000 abstract description 14
- 230000001939 inductive effect Effects 0.000 abstract description 7
- 238000000799 fluorescence microscopy Methods 0.000 abstract description 6
- 235000012239 silicon dioxide Nutrition 0.000 abstract description 3
- 238000001215 fluorescent labelling Methods 0.000 abstract description 2
- 238000004458 analytical method Methods 0.000 abstract 1
- 230000029918 bioluminescence Effects 0.000 abstract 1
- 238000005415 bioluminescence Methods 0.000 abstract 1
- 230000003013 cytotoxicity Effects 0.000 abstract 1
- 231100000135 cytotoxicity Toxicity 0.000 abstract 1
- 238000007877 drug screening Methods 0.000 abstract 1
- 238000010859 live-cell imaging Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 238000002189 fluorescence spectrum Methods 0.000 description 9
- 230000002776 aggregation Effects 0.000 description 6
- 238000004220 aggregation Methods 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 239000012620 biological material Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- -1 fluorescent mark Substances 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000004530 micro-emulsion Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- MFFMQGGZCLEMCI-UHFFFAOYSA-N 2,4-dimethyl-1h-pyrrole Chemical compound CC1=CNC(C)=C1 MFFMQGGZCLEMCI-UHFFFAOYSA-N 0.000 description 1
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 1
- PAPNRQCYSFBWDI-UHFFFAOYSA-N DMP Natural products CC1=CC=C(C)N1 PAPNRQCYSFBWDI-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- OSOSMTZOKLTVFS-UHFFFAOYSA-N S(=O)(=O)(O)C(C(=O)O)CC(=O)O.C(C)C(C[Na])CCCC Chemical compound S(=O)(=O)(O)C(C(=O)O)CC(=O)O.C(C)C(C[Na])CCCC OSOSMTZOKLTVFS-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000004064 cosurfactant Substances 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000000593 microemulsion method Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- WVIICGIFSIBFOG-UHFFFAOYSA-N pyrylium Chemical compound C1=CC=[O+]C=C1 WVIICGIFSIBFOG-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6402—Atomic fluorescence; Laser induced fluorescence
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1059—Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
本发明公开了一种萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY。本发明还公开了该萘酰亚胺-氟硼二吡咯荧光分子的制备方法及其应用。本发明的萘酰亚胺-氟硼二吡咯荧光分子通过1,3-偶极环加成反应制备，该分子存在从萘酰亚胺能量给体到氟硼二吡咯能量受体之间的分子内荧光共振能量转移，具有聚集诱导荧光性质。萘酰亚胺-氟硼二吡咯荧光分子稳定性好，细胞毒性低，荧光性能优异，可作为有机荧光染料用于制备染料负载的二氧化硅荧光纳米粒子以及肿瘤细胞荧光成像，在活细胞成像、荧光传感器、生物荧光分析、荧光标记、药物高通量筛选等领域具有极为重要的应用。
Description
技术领域
本发明涉及荧光化合物及其制备和应用领域，具体涉及一种萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY及其制备方法和应用。
背景技术
氟硼二吡咯荧光分子的摩尔消光系数大，荧光量子产率高，荧光谱峰窄，灵敏度高，稳定好，具有优良的光学性能，可广泛用于生物荧光分析领域，是近年来的研究热点。萘酰亚胺-氟硼二吡咯复合荧光分子在文献中鲜有报道，其荧光性能优异，荧光量子效率高，存在从萘酰亚胺能量给体到氟硼二吡咯能量受体之间的分子内荧光共振能量转移，具有聚集诱导荧光性质，可作为有机荧光染料用于制备染料负载的二氧化硅荧光纳米粒子以及肿瘤细胞荧光成像，在活细胞成像、荧光传感器、生物荧光分析、荧光标记、药物高通量筛选等领域具有极为重要的应用。
发明内容
发明目的：本发明所要解决的第一个技术问题是提供了一种萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY。
本发明所要解决的第二个技术问题是提供了一种萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY的制备方法。
本发明所要解决的第三个技术问题是提供了一种萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY的应用。
本发明通过铜催化的1,3-偶极环加成反应，制备得到一种新型萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY。该荧光分子在现有技术中未见报道，具有聚集诱导荧光性质，并且存在分子内荧光共振能量转移。该萘酰亚胺-氟硼二吡咯荧光分子可作为荧光性能优异的有机染料用于制备染料负载二氧化硅荧光纳米粒子以及用于肿瘤细胞荧光成像，在活细胞成像、荧光传感器、生物荧光标记等领域具有极为重要的应用价值。
技术方案：为了解决上述技术问题，本发明提供了一种萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY，由如下结构式构成：
上述的萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY的制备方法，所述萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY由8-[4-(2-叠氮乙氧基)苯基]-1,3,5,7-四甲基-氟硼二吡咯(BODIPY)和N-正丁基-4-乙炔基-1,8-萘二甲酰亚胺(Ey-NP)通过1,3-偶极环加成反应得到，反应在二氯甲烷、乙醇和纯水的混合溶液中进行，以五水合硫酸铜和抗坏血酸钠、三乙胺为催化体系，具体反应式如下：
上述的萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY在作为染料负载荧光纳米粒子制备方面的应用。
上述的萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY在肿瘤细胞成像方面的应用。
上述的萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY作为分子内荧光共振能量转移荧光化合物的应用。
有益效果：本发明具有以下优点：本发明的新型荧光化合物包含N-正丁基-1,8-萘二甲酰亚胺和8-烷氧苯基-1,3,5,7-四甲基氟硼二吡咯两种复合荧光团，其荧光性能优异，荧光量子效率高，存在从萘酰亚胺能量给体到氟硼二吡咯能量受体之间的分子内荧光共振能量转移，具有聚集诱导荧光性质，可作为有机荧光染料用于制备染料负载的二氧化硅荧光纳米粒子以及肿瘤细胞荧光成像，在活细胞成像、荧光传感器、生物荧光分析、荧光标记、药物高通量筛选等领域具有极为重要的应用。萘酰亚胺-氟硼二吡咯荧光化合物NP-BODIPY的结构、合成、荧光性质及应用在现有文献中未见报道。
附图说明
图1是萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY在四氢呋喃溶液中的荧光光谱(NP-BODIPY浓度为10-5mol/L)；
图2为负载NP-BODIPY染料的二氧化硅荧光纳米粒子的透射电镜图；
图3为萘酰亚胺-氟硼二吡咯荧光染料NP-BODIPY负载的二氧化硅纳米粒子在纯水溶液中的荧光光谱(NP-BODIPY浓度为10-6mol/L)；
图4为萘酰亚胺-氟硼二吡咯荧光染料NP-BODIPY与乳腺癌细胞MCF-7共同孵化后的激光共聚焦荧光显微照片。
具体实施方式
实施例1萘酰亚胺-氟硼二吡咯荧光分子的制备
化合物BODIPY按文献方法制备(HuanrenCheng,YingQian.IntramolecularfluorescenceresonanceenergytransferinanovelPDI-BODIPYdendriticstructure:synthesis,Hg2+sensorandlivingcellimaging,SensorsandActuatorsB,2015,219,57-64)。具体合成方法如下：
将3.09g(13.55mmol)的4-(2-溴乙氧基)苯甲醛和1.03g(15.85mmol)的叠氮化钠溶于45mLDMF中，室温下磁力搅拌反应24h，然后将反应液倒入45mL冰水中，萃取，洗涤，干燥，减压蒸馏，得到2.50g(4-(2-叠氮基乙氧基)苯甲醛)，将其溶于150mL二氯甲烷溶液中，继续加入2.48g(0.026mol)2,4-二甲基吡咯，滴加两滴三氟乙酸，室温搅拌下反应12h。然后向反应液中加入3.17g(0.013mol)四氯苯醌，继续搅拌12h，再向混合液中加入15mL三乙胺和15mL三氟化硼乙醚络合物，在0℃下反应12h。结束反应，萃取，洗涤，干燥，柱色谱提纯，得到BODIPY红色固体。产率25％。分析所得化合物BODIPY：
FT-IR(KBr):2960,2923,2860,2119,2106,1605,1544,1507,1370,1192,1054,838,761cm-1
1HNMR(CDCl3,300MHz)δ:7.18(d,J＝8.34Hz,2H),7.01(d,J＝8.37Hz,2H),5.97(s,2H),4.12(t,J1＝5.85HzJ2＝5.85Hz,2H),3.58(t,J1＝6.51HzJ2＝6.45Hz,2H),2.55(s,6H),1.43(s,6H)。
化合物Ey-NP的制备按文献方法制备(HuiminGuo,MariaL.Muro-Small,ShaominJi,JianzhangZhao,FelixN.Castellano.Naphthalimidephosphorescencefinallyexposedinaplatinum(II)diiminecomplex.Inorg.Chem.,2010,49,6802-6804)。
萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY的制备
氮气保护及磁力搅拌下，在15mL二氯甲烷/乙醇/纯水混合溶液(二氯甲烷/乙醇/纯水的体积比为12:1:1)中分别加入0.14g(0.34mmol)BODIPY和0.10g(0.36mmol)Ey-NP，充分搅拌下继续加入抗坏血酸钠0.041g(0.20mmol)和五水合硫酸铜0.026g(0.10mmol)，滴加三乙胺1mL，室温反应48h。结束反应，向反应体系加入15mL水，萃取，干燥，柱色谱提纯，得到红色固体即化合物NP-BODIPY，产率为65％。
化合物NP-BODIPY的合成路线如下：
分析所得化合物NP-BODIPY：
核磁共振氢谱1HNMR(CDCl3,ppm):δ9.11(d,J＝7.89Hz,1H),8.71(t,J1＝4.86Hz,J2＝5.04Hz,2H),8.27(s,1H),8.05(d,J1＝7.08Hz,1H),7.86(t,J1＝7.53HzJ2＝7.47Hz,1H),7.29(d,J＝7.71Hz,2H),7.11(d,J＝7.5Hz,2H),6.02(s,2H),5.04(s,2H),4.62(s,2H),4.27(t,J1＝6.27HzJ2＝6.63Hz,2H),2.60(s,6H),1.81(t,J1＝6.30HzJ2＝6.90Hz,2H),1.65(s,2H),1.44(s,6H),1.05(t,J1＝7.08HzJ2＝6.75Hz,3H)。
核磁共振碳谱13CNMR(CDCl3,ppm):δ160.92,135.07,134.00,133.24,132.24,129.97,129.89,127.23,123.81,117.68,68.98,55.97,52.67,42.91,32.80,22.97,17.15,16.39。
高分辨质谱HRMSCalcdforC39H37BF2N6O3Na[M+Na]+709.2880Found709.2818。
所获得化合物NP-BODIPY的结构式为：
实施例2萘酰亚胺-氟硼二吡咯荧光分子的光物理性质
测定了萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY及其荧光组成单元氟硼二吡咯、萘酰亚胺的紫外吸收及荧光光谱。NP-BODIPY的紫外吸收峰位于366和500nm。NP-BODIPY的荧光光谱呈双峰结构，荧光峰位于430和510nm，最大荧光发射波长510nm处的荧光峰强度是其氟硼二吡咯荧光单元的两倍。萘酰亚胺-氟硼二吡咯荧光化合物NP-BODIPY存在很强的分子内荧光共振能量转移，其中萘酰亚胺荧光单元作为能量给体，氟硼二吡咯荧光单元是能量受体。图1是萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY(浓度为10-5mol/L)在四氢呋喃溶液中的荧光光谱。
实验发现萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY具有聚集诱导荧光性质。NP-BODIPY固体粉末在暗室中紫外灯下呈紫红色荧光；NP-BODIPY的THF溶液呈绿色荧光；NP-BODIPY在含水量为70％的H2O/THF混合溶液中荧光较强，量子产率为0.60。
具有荧光共振能量转移的萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY在文献中未有报道，并且首次发现该分子具有聚集诱导荧光性质，萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY在有机发光器件，荧光传感器，生物标记及荧光探针等领域具有广阔的应用前景。
实施例3萘酰亚胺-氟硼二吡咯染料负载二氧化硅纳米粒子在水中的荧光性质
采用正相微乳液法制备并用纤维素透析膜透析得到了负载萘酰亚胺-氟硼二吡咯荧光染料NP-BODIPY的二氧化硅荧光纳米粒子(NP-BODIPY/SiO2)。具体方法如下：
将二(2-乙基己基)琥珀酸磺酸钠(AOT,0.22g)溶解在10mL去离子水中搅拌至澄清。0℃，超声下向其中加入0.4mL助表面活性剂正丁醇形成水包油的正相微乳液体系。将30μL含物质的量浓度为12mMNP-BODOIPY的DMF溶液缓慢加入微乳液体系中，超声3min后将0.1mL乙烯基三乙氧基硅烷(VTES)加入体系。室温下搅拌8h后加入10μL3-氨基丙基三乙氧基硅烷(APTES)，继续在室温下搅拌24h，反应结束后，未反应的成分用截留分子量为8-14kDa的纤维素透析膜透析72h，将所得溶液在5℃下保存即得。
染料NP-BODIPY被包裹在二氧化硅纳米粒子内，形成稳定的核-壳结构，呈单分散球形，分布均匀，平均粒径为50nm。图2为负载NP-BODIPY染料的二氧化硅荧光纳米粒子的透射电镜图。
测定了二氧化硅荧光纳米粒子在纯水中的荧光性质。图3为染料负载二氧化硅荧光纳米粒子在纯水中的荧光光谱。在水中二氧化硅荧光纳米粒子荧光光谱与在纯THF中的荧光光谱类似，峰形保持不变，在425nm和510nm呈现双峰结构，荧光强度较大。负载NP-BODIPY染料的二氧化硅荧光纳米粒子易溶于水中，表面富含大量活性氨基，易于修饰，生物相容性好，荧光性质优良，可作为生物分子荧光探针用于生物荧光分析、药物高通量筛选等生命科学领域。
实施例4萘酰亚胺-氟硼二吡咯荧光分子用于肿瘤细胞荧光成像
将萘酰亚胺-氟硼二吡咯荧光染料NP-BODIPY与乳腺癌细胞MCF-7共同孵化后在双通道共聚焦荧光显微镜下观察MCF-7细胞成像照片。图4为MCF-7细胞与荧光染料NP-BODIPY共同孵化后的激光共聚焦荧光成像照片。在MCF-7细胞中加入荧光染料NP-BODIPY共同孵化后，荧光染料进入MCF-7细胞内部清晰成像。萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY可用于肿瘤细胞成像。
本发明的实例化合物萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY经铜催化叠氮-炔环加成反应制备得到，荧光性能优良，存在分子内荧光共振能量转移，具有聚集诱导荧光性质，可用于制备染料负载的二氧化硅荧光纳米粒子，可作为有机染料用于肿瘤细胞荧光成像，在活细胞成像、荧光传感器、生物荧光分析、荧光标记、药物高通量筛选等领域具有极为重要的应用。
以上所述仅是本发明的优选实施方式，应当指出：对于本技术领域的技术人员来说，在不脱离本发明原理的前提下，还可以做出若干改进和润饰，这些改进和润饰也应视为本发明的保护范围。
Claims (5)
1.一种萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY，其特征在于，由如下结构式构成：
2.权利要求1所述的萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY的制备方法，其特征在于，所述萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY由8-[4-(2-叠氮乙氧基)苯基]-1,3,5,7-四甲基-氟硼二吡咯和N-正丁基-4-乙炔基-1,8-萘二甲酰亚胺通过1,3-偶极环加成反应得到，反应在二氯甲烷、乙醇和纯水的混合溶液中进行，以五水合硫酸铜和抗坏血酸钠、三乙胺为催化体系，具体反应式如下：
3.权利要求1所述的萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY在作为染料负载荧光纳米粒子制备方面的应用。
4.权利要求1所述的萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY在肿瘤细胞成像方面的应用。
5.权利要求1所述的萘酰亚胺-氟硼二吡咯荧光分子NP-BODIPY作为分子内荧光共振能量转移荧光化合物的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510766781.XA CN105440065B (zh) | 2015-11-11 | 2015-11-11 | 一种萘酰亚胺‑氟硼二吡咯荧光分子np‑bodipy及其制备方法和应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510766781.XA CN105440065B (zh) | 2015-11-11 | 2015-11-11 | 一种萘酰亚胺‑氟硼二吡咯荧光分子np‑bodipy及其制备方法和应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105440065A true CN105440065A (zh) | 2016-03-30 |
| CN105440065B CN105440065B (zh) | 2017-09-19 |
Family
ID=55550756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510766781.XA Active CN105440065B (zh) | 2015-11-11 | 2015-11-11 | 一种萘酰亚胺‑氟硼二吡咯荧光分子np‑bodipy及其制备方法和应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105440065B (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107661510A (zh) * | 2017-07-31 | 2018-02-06 | 江苏大学 | 甲氧基氟硼吡咯‑核酸‑四氧化三铁复合物及制备方法 |
| CN107782893A (zh) * | 2017-11-18 | 2018-03-09 | 安徽师范大学 | 一种检测叶酸功能化二氧化硅靶向纳米药物载体的方法 |
| CN109916866A (zh) * | 2019-03-04 | 2019-06-21 | 三峡大学 | 一种七元氟硼荧光染料的新用途 |
| CN112250700A (zh) * | 2020-09-04 | 2021-01-22 | 南京师范大学 | 氟硼二吡咯类蛋白质错误折叠探针Halo-BODIPY及其制备方法与应用 |
| WO2021188392A1 (en) * | 2020-03-20 | 2021-09-23 | Nitto Denko Corporation | Boron-containing cyclic emissive compounds and color conversion film containing the same |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103333682A (zh) * | 2013-07-24 | 2013-10-02 | 南京大学 | 一种比例型近红外荧光探针及其制备方法和应用 |
| CN104592244A (zh) * | 2015-01-07 | 2015-05-06 | 东南大学 | 一种罗丹明-萘二甲酰亚胺荧光分子及其制备方法和应用 |
| CN105017300A (zh) * | 2015-06-30 | 2015-11-04 | 东南大学 | 一种苝二酰亚胺-氟硼二吡咯荧光树形分子及其制备方法和应用 |
-
2015
- 2015-11-11 CN CN201510766781.XA patent/CN105440065B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103333682A (zh) * | 2013-07-24 | 2013-10-02 | 南京大学 | 一种比例型近红外荧光探针及其制备方法和应用 |
| CN104592244A (zh) * | 2015-01-07 | 2015-05-06 | 东南大学 | 一种罗丹明-萘二甲酰亚胺荧光分子及其制备方法和应用 |
| CN105017300A (zh) * | 2015-06-30 | 2015-11-04 | 东南大学 | 一种苝二酰亚胺-氟硼二吡咯荧光树形分子及其制备方法和应用 |
Non-Patent Citations (6)
| Title |
|---|
| "Switching of the Triplet Excited State of Styryl2,6-Diiodo-Bodipy and Its Application in Acid-Activatable Singlet Oxygen Photosensitizing";Ling Huang et al.;《J. Org. Chem.》;20141003;第79卷(第21期);第10240-10255页 * |
| "基于跨键能量转移机理新型氟硼吡咯类荧光染料的合成";刘涛;《承德石油高等专科学校学报》;20140815;第16卷(第4期);第51-52,56页 * |
| HUAN-REN CHENG ET AL.: ""Synthesis and fluorescence properties of a borondipyrrin functionalized perylenediimide derivative"", 《RSC ADV.》 * |
| LING HUANG ET AL.: ""Switching of the Triplet Excited State of Styryl2,6-Diiodo-Bodipy and Its Application in Acid-Activatable Singlet Oxygen Photosensitizing"", 《J. ORG. CHEM.》 * |
| SANJOY MUKHERJEE ET AL.: ""Fine-Tuning Dual Emission and Aggregation-Induced Emission Switching in NPI–BODIPY Dyads"", 《CHEM. EUR. J.》 * |
| 刘涛: ""基于跨键能量转移机理新型氟硼吡咯类荧光染料的合成"", 《承德石油高等专科学校学报》 * |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107661510A (zh) * | 2017-07-31 | 2018-02-06 | 江苏大学 | 甲氧基氟硼吡咯‑核酸‑四氧化三铁复合物及制备方法 |
| CN107661510B (zh) * | 2017-07-31 | 2020-07-31 | 江苏大学 | 甲氧基氟硼吡咯-核酸-四氧化三铁复合物及制备方法 |
| CN107782893A (zh) * | 2017-11-18 | 2018-03-09 | 安徽师范大学 | 一种检测叶酸功能化二氧化硅靶向纳米药物载体的方法 |
| CN107782893B (zh) * | 2017-11-18 | 2019-06-04 | 安徽师范大学 | 一种检测叶酸功能化二氧化硅靶向纳米药物载体的方法 |
| CN109916866A (zh) * | 2019-03-04 | 2019-06-21 | 三峡大学 | 一种七元氟硼荧光染料的新用途 |
| WO2021188392A1 (en) * | 2020-03-20 | 2021-09-23 | Nitto Denko Corporation | Boron-containing cyclic emissive compounds and color conversion film containing the same |
| TWI760152B (zh) * | 2020-03-20 | 2022-04-01 | 日商日東電工股份有限公司 | 含硼環狀發光化合物和含有該含硼環狀發光化合物的色轉換膜 |
| JP2023517750A (ja) * | 2020-03-20 | 2023-04-26 | 日東電工株式会社 | 含ホウ素環式放出性化合物及びそれを含む色変換フィルム |
| JP7415034B2 (ja) | 2020-03-20 | 2024-01-16 | 日東電工株式会社 | 含ホウ素環式放出性化合物及びそれを含む色変換フィルム |
| CN112250700A (zh) * | 2020-09-04 | 2021-01-22 | 南京师范大学 | 氟硼二吡咯类蛋白质错误折叠探针Halo-BODIPY及其制备方法与应用 |
| CN112250700B (zh) * | 2020-09-04 | 2022-06-10 | 南京师范大学 | 氟硼二吡咯类蛋白质错误折叠探针Halo-BODIPY及其制备方法与应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105440065B (zh) | 2017-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105440065A (zh) | 一种萘酰亚胺-氟硼二吡咯荧光分子np-bodipy及其制备方法和应用 | |
| Nicol et al. | Functionalized AIE nanoparticles with efficient deep-red emission, mitochondrial specificity, cancer cell selectivity and multiphoton susceptibility | |
| CN101486903B (zh) | 一种基于吡啶二羧酸的稀土发光纳米粒子的制备方法 | |
| CN105669734B (zh) | 一种咔唑基三苯胺‑氟硼二吡咯荧光分子bcpa‑bodipy及其制备方法和应用 | |
| CN101993693B (zh) | 用于pH比率探针的介孔二氧化硅荧光纳米粒子制备方法 | |
| Qi et al. | Simultaneously boosting the conjugation, brightness and solubility of organic fluorophores by using AIEgens | |
| Tian et al. | Preparation and time-gated luminescence bioimaging applications of long wavelength-excited silica-encapsulated europium nanoparticles | |
| Hang et al. | Galactose functionalized diketopyrrolopyrrole as NIR fluorescent probes for lectin detection and HepG2 cell targeting based on aggregation-induced emission mechanism | |
| Zhang et al. | NIR‐II J‐aggregated Pt (II)‐porphyrin‐based phosphorescent probe for tumor‐hypoxia imaging | |
| CN108192596B (zh) | 一种包覆型羧基化SiO2荧光纳米球的制备方法 | |
| Xu et al. | Lanthanide-containing persistent luminescence materials with superbright red afterglow and excellent solution processability | |
| Li et al. | Light-emitting property of simple AIE compounds in gel, suspension and precipitates, and application to quantitative determination of enantiomer composition | |
| Wang et al. | Multi-stable fluorescent silica nanoparticles obtained from in situ doping with aggregation-induced emission molecules | |
| CN107384375A (zh) | 一种稀土发光二氧化硅杂化材料及其制备方法和应用 | |
| Yang et al. | Solvatochromic covalent organic frameworks for the low-level determination of trace water in organic solvents | |
| CN104276936A (zh) | 一种双芘类化合物及其荧光纳米聚集体和应用 | |
| JP2014503471A (ja) | 非常に効率的なエネルギー移動及び調整可能なストークシフトを特徴とする複数の色素がドープされたシリカナノ粒子 | |
| Zhu et al. | Rare earth upconversion luminescent composite based on energy transfer for specific and sensitive detection of cysteine | |
| CN106831719A (zh) | 一种多吡啶萘酰亚胺荧光树形分子及其制备方法和应用 | |
| CN103468260A (zh) | 具有上转换发光性质的pH纳米传感材料及其制备方法 | |
| Fan et al. | Controlling the Energy Relaxation: Organic Doping in AIEgen Nanoparticles for Highly Enhanced Intravital Two‐Photon Imaging | |
| CN108342190A (zh) | 一种比值式检测hno的纳米荧光探针及其制备方法和应用 | |
| CN102516793B (zh) | 一类双苄基五甲川菁荧光染料、其制备方法及应用 | |
| CN103242828A (zh) | 一种调节共轭聚电解质荧光性能的方法 | |
| CN104004508B (zh) | 一种导电性混金属聚合物薄膜材料的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |